For laboratory & research use only. Not for human consumption.
Weight Loss / Metabolic

MOTS-c Mechanism of Action

How a signaling peptide encoded inside mitochondrial DNA activates AMPK and travels to the nucleus to regulate metabolic gene expression.

A Peptide Encoded Inside Mitochondrial DNA

MOTS-c is a 16-amino-acid peptide encoded within a short open reading frame inside the mitochondrial 12S rRNA gene — not the cell's nuclear DNA, where essentially every other signaling peptide referenced on this site originates. This was a genuinely unexpected finding when Changhan David Lee's team at USC identified it in 2015: mitochondrial DNA simply wasn't thought to encode functional signaling peptides before that point.

Activating AMPK Signaling

Research models show that MOTS-c activates AMPK (AMP-activated protein kinase), a central cellular energy sensor that switches on when the cell's energy reserves (ATP) run low. AMPK activation shifts cellular metabolism toward energy-generating processes and away from energy-consuming ones, including increased glucose uptake and fatty acid oxidation — the mechanistic basis for MOTS-c's research use in metabolic and insulin-sensitivity models.

Retrograde Signaling to the Nucleus

Under metabolic stress, MOTS-c has been observed to translocate from the cytoplasm into the cell nucleus, where it interacts with nuclear transcription factors (including NRF2) to regulate the expression of genes involved in antioxidant response and metabolic regulation. This mitochondria-to-nucleus communication is described in the research literature as "retrograde signaling" — a mitochondrial molecule directly influencing which genes the nucleus expresses, rather than mitochondrial function being regulated one-way from the nucleus outward.

How This Differs From SS-31

MOTS-c and SS-31 are both mitochondria-focused compounds, but they work through entirely different mechanisms: MOTS-c is a diffusible signaling peptide that activates AMPK and travels to the nucleus to regulate gene expression, while SS-31 works structurally, binding cardiolipin directly on the inner mitochondrial membrane to stabilize it. See our full MOTS-c vs SS-31 comparison for more detail.

  • AMPK activation and cellular energy-sensing research
  • Mitochondria-to-nucleus retrograde signaling studies
  • Insulin sensitivity and metabolic regulation research
  • Comparative mitochondrial-mechanism research vs SS-31

Back to the full MOTS-c research overview →

Research Use Only Notice This page provides general research and educational context about MOTS-c's mechanism of action only, and does not constitute medical, dosing, or human-use advice. It is not a claim about current regulatory approval, safety, or legal status in any market. Any MOTS-c sourced through KYIN Peptides is sold strictly for laboratory research use by qualified professionals — not for human or animal use, and not intended for diagnostic, therapeutic, or consumption purposes.
FAQ

MOTS-c mechanism questions

Where is MOTS-c encoded?

MOTS-c is encoded within a short open reading frame inside the mitochondrial 12S rRNA gene, part of mitochondrial DNA rather than the cell's nuclear DNA — a discovery that opened up an entirely new research category now called mitochondrial-derived peptides (MDPs).

How does MOTS-c's mechanism differ from SS-31's?

MOTS-c is a diffusible signaling peptide that activates AMPK and travels to the cell nucleus to regulate gene expression, while SS-31 works structurally by binding cardiolipin on the inner mitochondrial membrane to stabilize it — two very different mechanisms despite both being mitochondria-focused.

Interested in MOTS-c?

See pricing and order on the product page, or browse our other weight-loss and metabolic peptides.